BioNxt Solutions (BNXTF) News Today $0.24 +0.03 (+14.88%) (As of 05:50 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period BioNxt Solutions Inc.: BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRPDecember 20, 2024 | finanznachrichten.deBioNxt Solutions Advances Multiple Sclerosis TreatmentDecember 10, 2024 | markets.businessinsider.comBioNxt Solutions Inc (BXT.MU)November 27, 2024 | finance.yahoo.comBioNxt Solutions Expands Innovative Drug Delivery PipelineNovember 25, 2024 | tipranks.comBioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative DiseasesOctober 29, 2024 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Solutions Announces ODF Cladribine Update and FinancingApril 26, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Commercialization of ODF Cladribine Product for MS Next StepsMarch 18, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine PK StudyMarch 13, 2024 | finanznachrichten.deBioNxt Solutions Inc.: BioNxt Reports Completion of ODF Cladribine PK StudyMarch 4, 2024 | finanznachrichten.deBioNxt Solutions finalizes debt settlement agreementFebruary 19, 2024 | msn.comBioNxt Solutions Finalizes AgreementFebruary 16, 2024 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine Toxicity StudyFebruary 7, 2024 | finanznachrichten.deBioNxt Reports Successful Results From ODF Cladribine Toxicity StudyFebruary 7, 2024 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private PlacementJanuary 30, 2024 | finanznachrichten.deBioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private PlacementJanuary 30, 2024 | finance.yahoo.comBioNxt Solutions Inc. (BNXT.CN)January 5, 2024 | ca.finance.yahoo.comBioNxt Solutions Inc.: BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and FinancingDecember 23, 2023 | finanznachrichten.deBioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and FinancingDecember 21, 2023 | finance.yahoo.comBioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery ProductsDecember 12, 2023 | finance.yahoo.comBioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s WarrantsDecember 9, 2023 | finance.yahoo.comBionxt Solutions Announces Convertible Debenture and Interest SettlementNovember 24, 2023 | benzinga.comBioNxt Solutions Inc.: BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis TreamentNovember 20, 2023 | finanznachrichten.deBioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis TreamentNovember 20, 2023 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Reports on New Cladrabine ODF Product Development and Commercialization ProgramNovember 16, 2023 | finanznachrichten.deBioNxt Reports on New Cladrabine ODF Product Development and Commercialization ProgramNovember 15, 2023 | finance.yahoo.comBioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple SclerosisNovember 13, 2023 | finance.yahoo.comBioNxt Solutions berichtet über CPHI-Kongress in BarcelonaNovember 6, 2023 | benzinga.comBioNxt Solutions Reports on Barcelona CPHI ConferenceNovember 6, 2023 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private PlacementOctober 27, 2023 | finanznachrichten.deBioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private PlacementOctober 27, 2023 | finance.yahoo.comBioNxt Solutions Inc.: BioNxt Solutions Announces Change of DirectorsOctober 3, 2023 | finanznachrichten.deBioNxt Solutions Announces Change of DirectorsOctober 3, 2023 | finance.yahoo.comBioNxt Solutions Inc.: Bionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private PlacementSeptember 28, 2023 | finanznachrichten.deBionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private PlacementSeptember 28, 2023 | finance.yahoo.comBionxt Solutions Announces Closing of First Tranche of Non-Brokered Private PlacementAugust 28, 2023 | finance.yahoo.comBioNxt Solutions announces ~$4M private placementAugust 7, 2023 | msn.comBioNxt Solutions Inc.: BioNxt Solutions Announces Non-Brokered Private PlacementAugust 4, 2023 | finanznachrichten.deBioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative DiseaseAugust 2, 2023 | benzinga.comBioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s DiseaseJuly 3, 2023 | finance.yahoo.comBioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's DiseaseMay 15, 2023 | benzinga.comBioNxt Solutions Inc (BNXT)May 10, 2023 | investing.comBioNxt Successfully Completes Pilot Study for Contract Development CustomerMay 10, 2023 | marketwatch.comBioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical CompanyApril 24, 2023 | marketwatch.comBioNxt buys state-of-the-art coating and cutting equipment to build out European commercial manufacturing capacityApril 18, 2023 | msn.comBioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing CapacityApril 17, 2023 | benzinga.comBioNxt Reports on Enteric Coating Drug Delivery ProgramApril 15, 2023 | benzinga.comBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock OptionsApril 4, 2023 | finanznachrichten.deBioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock OptionsApril 4, 2023 | benzinga.comBioNxt Solutions Inc.: BioNxt Solutions Closes First Tranche of FinancingMarch 28, 2023 | finanznachrichten.deBioNxt Solutions Closes First Tranche of FinancingMarch 28, 2023 | finance.yahoo.com Get BioNxt Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BNXTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. BNXTF Media Mentions By Week BNXTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNXTF News Sentiment▼1.260.54▲Average Medical News Sentiment BNXTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNXTF Articles This Week▼10▲BNXTF Articles Average Week Get BioNxt Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BNXTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALLK News MGRM News PYXS News ASXC News ORMP News SY News ASMB News EDTXF News MIST News COYA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BNXTF) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNxt Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNxt Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
